Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Efficacy and safety of ceritinib in ALK-positive non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LW: Results from the phase II, ASCEND-7 study Barlesi, F., Kim, D., Bertino, E. M., van den Bent, M. J., Wakelee, H., Wen, P. Y., Garrido Lopez, P., Orlov, S., Majem, M., McKeage, M., Yu, C., Hurtado, F. K., Arratia, P., Song, Y., Branle, F., Shi, M., Chow, L. Q. OXFORD UNIV PRESS. 2019: 143-+
View details for Web of Science ID 000491295501207